4.5 Article

Applying Tobacco Carcinogen and Toxicant Biomarkers in Product Regulation and Cancer Prevention

Journal

CHEMICAL RESEARCH IN TOXICOLOGY
Volume 23, Issue 6, Pages 1001-1008

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/tx100056m

Keywords

-

Funding

  1. National Institutes of Health [CA-81301, CA-85702, CA-92025, CA-129534, DA-13333, ES-11297, NO1-CP-64402]

Ask authors/readers for more resources

Tobacco carcinogen and toxicant biomarkers arc metabolites or protein or DNA adducts of specific compounds in tobacco products. Highly reliable analytical methods, based mainly on mass spectrometry, have been developed and applied in large studies of many of these biomarkers. A panel of tobacco carcinogen and toxicant biomarkers is suggested here, and typical values for smokers and nonsmokers are summarized. This panel of biomarkers has potential applications in the new and challenging area of tobacco product regulation and in the development of rational approaches to cancer prevention by establishing carcinogen and toxicant uptake and excretion in people exposed to tobacco products.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available